Dic Score Calculator
Calculate the ISTH disseminated intravascular coagulation score from labs. Enter values for instant results with step-by-step formulas.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
ISTH DIC Score = Platelet score (0-2) + Fibrin marker score (0-3) + PT score (0-2) + Fibrinogen score (0-1)
The ISTH scoring system assigns points for four laboratory parameters: platelet count (0 for >100K, 1 for 50-100K, 2 for <50K), fibrin-related markers like D-dimer (0 for normal, 2 for moderate, 3 for strong increase), PT prolongation (0 for <3s, 1 for 3-6s, 2 for >6s), and fibrinogen level (0 for >100 mg/dL, 1 for <100 mg/dL). Score of 5 or greater indicates overt DIC.
Worked Examples
Example 1: Overt DIC in Sepsis
Problem:A 65-year-old with gram-negative sepsis has platelets 45,000, D-dimer strongly elevated (>10x ULN), PT prolonged by 5 seconds, and fibrinogen 90 mg/dL. Calculate the ISTH DIC score.
Solution:Platelet count 45,000 (50-100K range): 1 point D-dimer strongly elevated: 3 points PT prolonged by 5 seconds (3-6 sec range): 1 point Fibrinogen 90 mg/dL (<100): 1 point Total ISTH DIC Score: 1 + 3 + 1 + 1 = 6 Threshold for overt DIC: 5 or greater Diagnosis: Overt DIC
Result:ISTH DIC Score: 6/8 - Compatible with overt DIC; initiate treatment and repeat daily
Example 2: Non-Overt DIC Requiring Monitoring
Problem:A 42-year-old with acute pancreatitis has platelets 120,000, D-dimer moderately elevated, PT normal, and fibrinogen 180 mg/dL. Calculate the ISTH DIC score.
Solution:Platelet count 120,000 (>100K): 0 points D-dimer moderately elevated: 2 points PT not prolonged: 0 points Fibrinogen 180 mg/dL (>100): 0 points Total ISTH DIC Score: 0 + 2 + 0 + 0 = 2 Threshold for overt DIC: 5 or greater Diagnosis: Not overt DIC, suggestive
Result:ISTH DIC Score: 2/8 - Suggestive but not overt DIC; repeat scoring in 1-2 days
Frequently Asked Questions
What is disseminated intravascular coagulation (DIC)?
Disseminated intravascular coagulation (DIC) is a serious and potentially life-threatening condition characterized by widespread activation of the coagulation cascade, leading to the formation of small blood clots throughout the vasculature. This pathological process simultaneously consumes clotting factors and platelets, paradoxically resulting in both thrombosis and hemorrhage. DIC is always a secondary condition triggered by an underlying disorder such as sepsis, severe trauma, obstetric complications, malignancy, or severe transfusion reactions. The condition can present acutely with dramatic bleeding or chronically with predominantly thrombotic manifestations. Early recognition and treatment of the underlying cause are the cornerstones of DIC management.
How does the ISTH DIC scoring system work?
The International Society on Thrombosis and Haemostasis (ISTH) developed a standardized scoring system for diagnosing overt DIC based on readily available laboratory tests. The scoring algorithm requires an underlying disorder known to be associated with DIC as a prerequisite. Four laboratory parameters are then scored: platelet count (0-2 points based on degree of thrombocytopenia), elevated fibrin-related markers such as D-dimer or fibrin degradation products (0-3 points), prolonged prothrombin time (0-2 points), and fibrinogen level (0-1 point). The maximum possible score is 8 points. A total score of 5 or greater is compatible with overt DIC, while a score below 5 is suggestive but not confirmatory, warranting repeat testing in 1-2 days.
What laboratory tests are used to diagnose DIC?
The diagnosis of DIC relies on a combination of laboratory tests that reflect the pathophysiology of simultaneous clotting and bleeding. The ISTH scoring system uses four key tests: platelet count to assess consumption, D-dimer or fibrin degradation products (FDPs) to detect ongoing fibrin formation and breakdown, prothrombin time (PT) to evaluate coagulation factor consumption, and fibrinogen level to assess this critical clotting protein. Additional useful tests include activated partial thromboplastin time (aPTT), thrombin time, antithrombin III levels, protein C levels, and peripheral blood smear showing schistocytes (fragmented red blood cells). Serial monitoring is essential because individual test values may be normal early in DIC, and trending is more informative than single measurements.
What are the most common causes of DIC?
DIC can be triggered by numerous underlying conditions across several categories. Infection and sepsis are the most common causes, accounting for approximately 30-40% of cases, with both bacterial (particularly gram-negative) and viral infections implicated. Trauma, including major surgery, burns, and crush injuries, is the second most common trigger through tissue factor release. Obstetric complications including placental abruption, amniotic fluid embolism, eclampsia, and retained dead fetus are important causes in the obstetric population. Malignancies, particularly acute promyelocytic leukemia, mucin-secreting adenocarcinomas, and other solid tumors can trigger DIC. Additional causes include severe transfusion reactions, vascular abnormalities such as large hemangiomas, envenomation from certain snake bites, and severe liver disease.
How is the treatment of DIC approached?
The treatment of DIC is primarily directed at managing the underlying cause while providing supportive care for the coagulation derangement. Treating the trigger, such as antibiotics for sepsis, delivery of the placenta in obstetric DIC, or chemotherapy for malignancy, is the single most important intervention. Supportive transfusion therapy includes platelet transfusion when counts fall below 10,000 or below 50,000 with active bleeding, cryoprecipitate to maintain fibrinogen above 100 mg/dL, and fresh frozen plasma when there is significant bleeding with prolonged PT. The role of heparin anticoagulation is controversial and generally reserved for cases with predominantly thrombotic manifestations such as purpura fulminans or venous thromboembolism. Antithrombin concentrate and recombinant activated protein C have been studied but are not standard treatments.
What is the difference between acute and chronic DIC?
Acute and chronic DIC represent different temporal presentations of the same pathological process with distinct clinical features. Acute DIC develops rapidly, often over hours, with dramatic bleeding manifestations including petechiae, ecchymoses, oozing from venipuncture sites, and mucosal bleeding. The laboratory profile shows marked thrombocytopenia, very elevated D-dimer, prolonged PT, and low fibrinogen. Acute DIC is most commonly associated with sepsis, major trauma, and obstetric emergencies. Chronic DIC, also called compensated DIC, develops gradually over weeks to months, allowing the liver to partially compensate for factor consumption. It more commonly presents with thrombotic complications rather than bleeding, and laboratory values may be only mildly abnormal. Chronic DIC is frequently associated with malignancies and retained dead fetus.
How do platelet counts change in DIC and what triggers the decline?
Platelet counts in DIC decline due to consumption in widespread microvascular thrombi and through activation and aggregation driven by thrombin generation. In acute DIC, platelet counts can fall rapidly and dramatically, sometimes to below 10,000 per microliter within hours. The rate of decline is often as informative as the absolute count, with a rapidly falling trend being highly suggestive of DIC even before counts reach critically low levels. Platelet consumption exceeds bone marrow production capacity in acute DIC. Additional mechanisms of thrombocytopenia include immune-mediated destruction and sequestration in the microvasculature. Serial platelet count monitoring, typically every 6-12 hours in acute settings, is essential for tracking DIC severity and response to treatment. Recovery of platelet count is one of the earliest signs of DIC resolution.
What role do fibrin degradation products play in DIC diagnosis?
Fibrin degradation products (FDPs) and D-dimer are critical markers in DIC diagnosis because they reflect the simultaneous formation and breakdown of fibrin that defines the condition. D-dimer is specifically formed when cross-linked fibrin is cleaved by plasmin, making it more specific for fibrinolysis than general FDPs. In DIC, D-dimer levels are markedly elevated, often exceeding 10 times the upper limit of normal. The elevation reflects the intense activation of both the coagulation cascade (forming fibrin) and the fibrinolytic system (breaking down fibrin). However, elevated D-dimer is not specific to DIC and can occur in many conditions including venous thromboembolism, post-surgical states, inflammation, malignancy, and pregnancy. The ISTH scoring system assigns up to 3 points for fibrin marker elevation, making it the highest-weighted parameter in the DIC score.
How does the prothrombin time change in DIC?
The prothrombin time (PT) becomes prolonged in DIC due to consumption of coagulation factors, particularly factors V, VIII, and fibrinogen, which are depleted by the ongoing coagulation activation. The degree of PT prolongation reflects the severity of factor depletion and is graded in the ISTH DIC score as no prolongation (0 points), prolonged by 3-6 seconds (1 point), or prolonged by more than 6 seconds (2 points). The PT is particularly useful because it reflects the overall function of the extrinsic and common coagulation pathways. However, PT can also be affected by liver disease, vitamin K deficiency, and warfarin therapy, which must be considered in the differential diagnosis. Serial PT measurements showing progressive prolongation in the setting of an underlying DIC-causing condition are highly suggestive of the diagnosis.
When should the ISTH DIC score be repeated and how is it used for monitoring?
The ISTH DIC scoring system was designed for serial monitoring, and the timing of repeat assessments depends on the clinical situation. For patients with scores below 5 (suggestive but not overt DIC), the ISTH recommends repeating the score every 1-2 days to detect progression to overt DIC. For patients with overt DIC (score 5 or higher), daily scoring is recommended to monitor treatment response and disease trajectory. A declining score indicates improvement and successful treatment of the underlying cause, while a rising score suggests worsening DIC requiring more aggressive intervention. Beyond the composite score, individual component trends provide valuable clinical information, as platelet recovery often precedes normalization of coagulation times. The serial nature of the scoring system is one of its greatest strengths, as DIC is a dynamic process that requires ongoing reassessment.
References
- Taylor FB et al. Towards definition, clinical and laboratory criteria, and a scoring system for DIC. Thromb Haemost. 2001;86(5):1327-1330
- Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of DIC. Br J Haematol. 2009;145(1):24-33
- Wada H et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11(4):761-767
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist ยท Editorial policy
Related Calculators
๐งฎChads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
๐งฎCha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
๐งฎHas-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
๐งฎHEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
๐งฎTIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.
๐งฎWells Score Dvt Calculator
Estimate pre-test probability of deep vein thrombosis using the Wells clinical criteria.
๐งฎWells Score PE Calculator
Estimate pre-test probability of pulmonary embolism using the Wells criteria.
๐งฎFramingham Risk Score Calculator
Calculate 10-year cardiovascular disease risk using the Framingham risk assessment model.